INTRODUCTION
Epithelial tight junctions serve to regulate the passage of ions and molecules between cells, and to mark the division between apical and basolateral surfaces of cells in cellular differentiation (21) .
Thus, the disruption of intestinal epithelial tight junctions has two undesirable consequences: unwanted substances such as endotoxins are allowed into the body, and depolarization of cells may be promoted (17, 31) . Therefore, the maintenance of tight junctions is of critical importance to the functions of epithelia. Tight junctions are complex assemblies of transmembrane proteins (occludin, claudins, junctional adhesion molecules) (1), scaffolding proteins (zona occludens family, including ZO-1) (8),
and signaling proteins such as protein kinases (2) and protein phosphatases (34) . The interactions among these molecules keep the tight junctions intact and help to maintain epithelial polarization under normal conditions (39) . Interactions of injurious factors with tight junctions may cause dissociation of the protein complex. Internalization of dissociated proteins may weaken tight junctions, resulting in increased transepithelial permeability.
Acetaldehyde, a metabolic product of ethanol, is highly toxic to cells due to formation of adducts with DNA (5) and proteins (4, 22, 40) , leading to epigenetic and posttranslational consequences in different cells (13, 43) . Acetaldehyde is produced in the colonic lumen due to normal bacterial fermentation, which is elevated dramatically following alcohol consumption. High level of acetaldehyde is accumulated in the colonic lumen (28) .
Acetaldehyde at concentration of 200-400 μM has been detected in plasma and saliva of alcoholics. Due to volatility of acetaldehyde, its quantitation in biological fluids is considered under estimated. Highest level of acetaldehyde is developed in the colonic lumen due to oxidation of ethanol by microbial alcohol dehydrogenase; colonic microflora express very low level of aldehyde dehydrogenase. Acetaldehyde concentration in rat colonic lumen following alcohol administration was recorded as high as one mM. A significant body of evidence indicates that ethanol consumption induces intestinal epithelial barrier dysfunction and increased gut permeability leading to endotoxemia in human subjects and experimental animals (27, 28, 31) . In the intestinal epithelial cell monolyerss in vitro, ethanol is less effective in disruption of tight junctions (10, 30) . On the other hand, acetaldehyde disrupts tight junctions and increases paracellular permeability in Caco-2 cell monolayers (30) . The precise mechanism involved in acetaldehyde-induced tight junction disruption is poorly understood.
Occludin, one of the transmembrane proteins of tight junctions, is phosphorylated on several evolutionarily conserved serine and threonine residues (32) . Previous studies have shown that these residues are dephosphorylated and occludin is internalized into the cell as the tight junction weakens in the presence of hydrogen peroxide (35) or calcium-free medium (34) . Protein phosphatase 2A (PP2A), a serine/threonine phosphatase, is a multimeric protein composed of catalytic "C" subunit, scaffolding "A" subunit and one of several regulatory "B" subunits (16). PP2A interacts with tight junctions and appears to play a role in the regulation of tight junction integrity likely by modulating the phosphorylation of tight junction proteins on specific serine or threonine residues (33, 37) . Few recent studies indicated that protein phosphatases are involved in ethanol-induced cellular dysfunction.
Activation of PP1 is involved in ethanol-induced T cell suppression in mesenteric lymph nodes (19) .
PP2A activation mediates ethanol-induced dysfunction of hepatocytes (18) and cardiomyocytes (20) .
The goal of our study was to investigate the role of PP2A in acetaldehyde-induced dephosphorylation of occludin and the disassembly of tight junctions. Caco-2 cell monolayers and mouse intestine were used as in vitro and ex vivo models of the intestinal epithelium. A selective pharmacological PP2A inhibitor, a PP2A translocation inhibitor peptide, and siRNA-mediated knock down of PP2A were applied to determine the role of PP2A in acetaldehyde-induced tight junction disruption.
EXPERIMENTAL

Reagents:
Cell culture reagents were purchased from Invitrogen and Fisher Scientific. FITCinulin, leupeptin, aprotinin, bestatin, pepstatin A, phenylmethylsulfonyl fluoride (PMSF), Triton-X-100, Malachite green and protein-A sepharose were purchased from Sigma Aldrich (St. Louis, MO).
Fostriecin and okadaic acid were purchased from Calbiochem EMD Chemicals (San Diego, CA).
Protein phosphatase substrate phosphopeptide (KRpTIRR) was purchased from Millipore (Billerica, MA). Scrambled control RNA and siRNA specific to human PP2A-Cα (smart pool of 3 different siRNA) were purchased from Dharmacon (Lafayette, CO). Inhibitory peptide TPDYFL and control peptide (PALFTA) were custom-synthesized by Genscript (Piscataway, NJ). All other chemicals were of analytical grade and purchased from Sigma Aldrich or Fisher Thermo Scientific (Tustin, CA).
Antibodies:
Mouse monoclonal anti-PP2A Cα (free and methylated) and anti-E-cadherin were purchased from BD Transduction (Franklin Lakes, NJ). Mouse monoclonal anti-occludin (free and HRP-conjugated) and rabbit polyclonal anti-ZO-1, anti-phospho-threonine, and anti-phospho-serine antibodies were purchased from Invitrogen (Carlsbad, CA). Alexa-fluor 488-conjugated anti-mouse IgG antibody was purchased from Molecular Probes (Eugene, OR). Cy3-conjugated anti-rabbit IgG antibodies were from Sigma-Aldrich.
Cell culture and transfection: Caco-2 cells purchased from the American Type Culture Collection were grown under standard culture conditions as described previously (30) . Cells from passages 9-40 were grown on polycarbonate membranes in transwell inserts for 7 days (6.5 mm), 11-14 days (12 mm) or 17-19 days (24 mm) and serum starved overnight prior to experimental treatments.
For siRNA transfection, Caco-2 cells (approximately 125,000 cells/well) were seeded in sixwell cluster plates. After 24 hours, cells were incubated in serum-free, antibiotic-free DMEM for an hour. Cells were transfected with siRNA or control RNA using 100 μL Optimem, 12 μl Plus reagent, and 7-μl oligofectamine with 150 μl DMEM and incubated for 6-8 hours. Medium containing 10% serum was added, and cells were incubated at 37°C until the next day. Cell monolayers were trypsinized and seeded onto Transwell inserts. Trans-epithelial electrical resistance (TER) was monitored daily, and experiments were conducted on days 3 or 4, when TER stabilized at levels indicating a confluent monolayer.
Acetaldehyde and inhibitor treatments: Acetaldehyde (200-400 μM) treatment was performed as previously described (3). Cells were pre-incubated in PBS containing 1.2 mM CaCl 2 and 1 mM MgCl 2 , bovine serum albumin, and glucose for one hour. Then cells were exposed to vapor-phase acetaldehyde to achieve 200-600 μM concentration in sealed culture plates (25). In some experiments cell monolayers were incubated with 50 nM fostriecin in DMEM in apical and basal wells for 16 hours before acetaldehyde treatment. Genistein (100 μM) was administered one hour prior to acetaldehyde treatment.
TPDYFL inhibitory peptide and corresponding control peptide were applied to cells using the Immunoprecipitation: Cells were washed with cold 20 mM Tris-HCl, pH 7.4, and proteins were extracted using lysis buffer N (20 mM Tris, pH 7.4, containing 150 mM NaCl, 10 μg/ml leupeptin, 10 μg/ml pepstatin A, 10 μg/ml aprotinin, 10 μg/ml bestatin, and 0.1 mM PMSF). Protein extracts (400 μg) were incubated with 2 μg anti-occludin antibodies overnight at 4°C on a rocker.
Immuno-complexes were precipitated with protein A/G conjugated sepharose beads. For PP2A phosphatase activity assays, beads were maintained on ice until the assay. For immunoblot analysis, beads were heated at 100°C for 10 minutes with Laemmli's sample buffer to release complexes.
Analysis of threonine phosphorylation:
Cells were lysed in lysis buffer D (0.3% SDS w/v, 10 mM Tris-HCl, pH 7.4, containing 10 μg/ml leupeptin, 10 μg/ml pepstatin A, 10 μg/ml aprotinin, 10 μg/ml bestatin, and 0.1 mM PMSF) pre-heated at 100°C. After repeated pipetting to homogenize samples, samples were heated at 100°C for 10 minutes. Protein extracts (400 μg) were incubated with anti-phospho-threonine antibodies overnight as described above. Protein complexes were immunoprecipitated with protein A sepharose beads and extracted in Laemmli's sample buffer.
PP2A activity assay: Anti-occludin immunocomplexes were resuspended in PPase buffer (50 mM HEPES, pH7.2, 60 mM NaCl, 60 mM KCl, and protease inhibitors) to a volume of 20 μl. These samples were incubated at 30°C for 10 minutes with 5μl (1 μg/μl) of phosphopeptide substrate. Free phosphate released during the activity was assayed by mixing with 100 μl malachite green in a 96-well microtiter plate and incubated at room temperature for 15 minutes. Absorbance was measured at 620 nm in a microplate reader (SpectraMax 190, Molecular Devices, Sunnydale, CA). The assay was performed in the presence or absence of 300 nM fostriecin and 100 nM okadaic acid. Units of PP2A activity represent picomoles of free phosphate generated under assay conditions.
Immunofluorescence microscopy: Cell monolayers were fixed in 4% paraformaldehyde in TBST (20 mM Tris, pH7.2, and 150 mM NaCl) for 15 minutes at room temperature. They were blocked in 4% milk in TBST, and then incubated with primary antibodies for 90 minutes followed by incubation with secondary antibodies for one hour. Fluorescence was visualized using a Zeiss LSM 5 laser scanning confocal microscope, and images from 1 μm-thick x-y sections were collected. Images were stacked using Image J software (National Institutes of Health, Bethesda, MD), and processed using Adobe Photoshop (Adobe Systems, San Jose, CA).
Preparation of detergent-insoluble fractions:
Cell monolayers were incubated for 15 min with lysis buffer-CS (Tris buffer containing 1.0% Triton-X100, 2 µg/ml leupeptin, 10 µg/ml aprotinin, 10 µg/ml bestatin, 10 µg/ml pepstatin-A, 1 mM vanadate and 1 mM PMSF). Cell lysates were centrifuged at 15,600 x g for 4 min at 4°C to sediment the high-density actin cytoskeleton (detergentinsoluble fraction). The "detergent-insoluble fraction" is likely to pull down lipid raft components along with F-actin filaments, and therefore contains more than just the actin cytoskeleton. Supernatant Immunoblot analysis: Proteins were separated by SDS-polyacrylamide gel (4-12 % gradient) electrophoresis and transferred to nitrocellulose PVDF membranes. Membranes were blotted for different proteins using specific antibodies in combination with HRP-conjugated anti-mouse IgG or HRP-conjugated anti-rabbit IgG antibodies. The blots were developed using ECL chemiluminescence method (Amersham, Arlington Heights, IL). The bands were quantitated by densitometric analysis using Image J software (NIH).
PP2A methylation:
The level of methylated PP2A-Cα in cell extracts was evaluated by immunoblot analysis using an antibody that specifically recognizes the methylated form of the PP2A C-subunit.
Acetaldehyde treatment of mouse intestine: These studies were conducted using an IACUC approved protocol. Adult male mice (C57BL/6; 12 weeks old) were used for these studies. Segments of ileum were flushed and slit open longitudinally to prepare intestinal sheets. These tissues were incubated in DMEM at 37°C with or without 50 nM fostriecin for 15 min followed by incubation with acetaldehyde (400 μM) for one hour. Similar to caco-2 cell monolayers, acetaldehyde treatment was performed by exposure of intestinal tissues to vapor phase acetaldehyde in sealed cluster plates.
Tissues were cryofixed in OCT and 10 μm cryosections were fixed and stained for occludin and ZO-1 by immunofluorescence staining method as described above.
Statistical analyses
Comparison between two groups was made by Student's t-tests for grouped data. Significance in all tests was set at 95% or greater confidence level.
RESULTS
Inhibition of PP2A activity attenuates acetaldehyde-induced barrier dysfunction and tight junction disruption.
Acetaldehyde is known to disrupt tight junctions and increase paracellular permeability in intestinal epithelium. However, the mechanism of acetaldehyde-induced tight junction disruption is poorly understood. The effects of endogenous PP2A activity on acetaldehyde-induced tight junction disruption were evaluated using the PP2A-selective inhibitor, fostriecin, in Caco-2 cell monolayers.
Acetaldehyde at 400 μM concentration increased unidirectional flux of inulin in a time-dependent manner, and pretreatment of cell monolayers with fostriecin significantly dampened this effect of acetaldehyde (Fig. 1A) . Fostriecin, by itself, produced no significant effect on inulin flux. Incubation of cell monolayers with 200-600 μM acetaldehyde for 5 hours did not significantly increase LDH activity in the incubation medium, indicating the absence of cell lysis by acetaldehyde under the present experimental conditions (Fig. 1B) . On the other hand, incubation of cells with 0.05% Triton X-100 for 10 min increased LDH level in the medium (positive control).
Immunofluorescence staining for tight junction proteins indicated that acetaldehyde exposure induced redistribution of occludin and ZO-1 from the intercellular junctions into intracellular compartments ( Fig. 2A) . Pretreatment with fostriecin attenuated acetaldehyde-induced redistribution of both occludin and ZO-1. Fostriecin in the absence of acetaldehyde appeared to enhance the junctional localization of occludin and ZO-1. Acetaldehyde exposure also resulted in redistribution of adherens junction proteins, E-cadherin and β-catenin; and this effect of acetaldehyde was blocked by fostriecin treatment (Fig. 2B) .
Knockdown of PP2A-Cα attenuates acetaldehyde-induced barrier dysfunction and tight junction disruption
To further confirm the role of PP2A in acetaldehyde-induced tight junction disruption, we knocked down PP2A-Cα using a specific siRNA targeted to the catalytic subunit of PP2A. PP2A-Cα level was significantly reduced by siRNA transfection (Fig. 3A) . Acetaldehyde increased inulin permeability in non-specific RNA-transfected cell monolayers. But in PP2A-specific siRNA transfected cell monolayers, acetaldehyde-induced inulin permeability was significantly lower than that in NS-RNA-transfected cells (Fig. 3B) . Knockdown of PP2A-Cα subunit also suppressed acetaldehyde-induced redistribution of occludin and ZO-1 from the intercellular junctions (Fig. 3C) .
Acetaldehyde induces dephosphorylation of occludin on threonine residues by a PP2A-dependent mechanism
Previous studies indicated that tight junction disruption by calcium depletion or hydrogen peroxide treatment is associated with occludin dephosphorylation on threonine residues (9, 33, 37).
The role of PP2A in acetaldehyde-induced tight junction disruption suggested that occludin dephosphorylation might be part of this effect. To determine the effect of acetaldehyde on occludin phosphorylation, we evaluated the levels of threonine -phosphorylated occludin in cells treated with acetaldehyde in the presence or absence of fostreicin. Acetaldehyde treatment rapidly reduced the level of threonine-phosphorylated occludin as early as 30 minutes of treatment (Fig. 4A & 4B) .
Pretreatment of cell monolayers with fostriecin significantly attenuated acetaldehyde-induced occludin dephosphorylation ( Fig. 4A & 4B) .
Acetaldehyde increases association of PP2A-Cα with occludin
To determine the effect of acetaldehyde on association of PP2A with the tight junction protein complex, we evaluated co-immunoprecipitation of PP2A with occludin in cell monolayers exposed to acetaldehyde for varying times. The fostriecin-sensitive protein threonine phosphatase activity in occludin-immunocomplexes was rapidly increased by acetaldehyde treatment (Fig. 5A ). Immunoblot analysis indicated that the association between occludin and PP2A also increased rapidly (Fig. 5B &   4C ). This increase in interaction between occludin and PP2A was confirmed by precipitation of PP2A using microcystin-conjugated beads and immunoblot analysis for occludin (data not shown).
PP2A translocation inhibitor prevents acetaldehyde-induced tight junction disruption
PP2A activity is known to be regulated by posttranslational modifications of the catalytic subunit by carboxymethylation of L309 at the C-terminal end (6) . The C-terminal sequence, TPDYFL, is conserved from yeast to humans (15), and was found to inhibit PP2A translocation in cardiac myocytes (7) . Therefore, we evaluated the effect of this peptide on acetaldehyde-induced occludin phosphorylation and tight junction disruption. TPDYFL significantly blocked acetaldehyde-induced increase in inulin permeability (Fig. 6A) ; the control peptide with scrambled sequence did not affect inulin permeability in untreated or acetaldehyde-treated cell monolayers (data not shown).
Acetaldehyde-induced redistribution of occludin and ZO-1 from the intercellular junctions was attenuated by TPDYFL (Fig 6B) , but not by scrambled peptide. TPDYL also blocked acetaldehydeinduced threonine-dephosphorylation of occludin (Fig. 6C) .
Tyrosine kinase activity mediates acetaldehyde-induced threonine-dephosphorylation of occludin
PP2A multimeric protein complex assembly and subcellular translocation are known to be regulated by carboxymethylation of L309 or phosphorylation of Y307 (6, 11, 26) . To determine the role of carboxymethylation of PP2A, we evaluated the effect of acetaldehyde on the level of methylated PP2A. Results showed a lack of significant change in methylated PP2A in acetaldehydetreated cells compared to control cells (Fig. 7A) , suggesting that change in methylation is not a part of the mechanism in acetaldehyde-induced tight junction disruption. Previous study demonstrated that tyrosine kinase activity plays a role in acetaldehyde-induced tight junction regulation (3). To determine the crosstalk between tyrosine kinase activity and PP2A activity we evaluated the effect of genistein on interaction between occludin and PP2A C-subunit and threonine phosphorylation of occludin.
Genistein significantly attenuated acetaldehyde-induced increase in co-immunoprecipitation of PP2A with occludin ( Fig. 7B ) and threonine dephosphorylation of occludin (Fig. 7C & 7D) . Acetaldehyde or genistein did not alter the level of total occludin in these cells (Fig. 7C) . Acetaldehyde treatment also caused threonine-dephosphorylation of claudin-5, but this effect of acetaldehyde was unaffected by genistein (Fig. 7C) .
Inhibition of PP2A activity suppresses acetaldehyde-induced tight junction disruption in mouse intestine
To establish the physiological significance of PP2A role in acetaldehyde-induced disruption of intestinal epithelial tight junctions, we determined the effect of acetaldehyde on tight junction integrity in mouse ileum ex vivo and the effect of fostriecin on acetaldehyde-mediated tight junction disruption.
Results show that occludin and ZO-1 were co-localized at the intercellular junctions of the epithelial monolayer in tissues incubated ex vivo without acetaldehyde, but exposure to acetaldehyde resulted in loss of junctional distribution of both occludin and ZO-1 (Fig. 8) . Pretreatment of tissue with fostriecin blocked acetaldehyde-induced redistribution of occludin and ZO-1 from the epithelial junctions. Fostriecin alone showed no considerable influence on the distribution of these tight junction proteins.
DISCUSSION
Acetaldehyde, the most toxic product of ethanol metabolism, is involved in tissue injury in different organ systems (23) . Although acetaldehyde is well known to disrupt intestinal epithelial tight junctions and increase paracellular permeability (3, 29, 30) , the mechanism involved in this process of tight junction disruption is poorly understood. Evidence indicates that intracellular signaling molecules, such as protein kinases and protein phosphatases regulate epithelial tight junctions (12).
Previous studies demonstrated that PP2A plays a crucial role in epithelial tight junction regulation (25, 33, 35) . Results of our present study indicate that PP2A translocation to tight junctions and PP2A-dependent dephosphorylation of occludin are involved in the mechanism of acetaldehyde-induced tight junction disruption.
Fostriecin is a selective inhibitor of PP2A activity (42) .
Our present study shows that Furthermore, PP2A activity was found to be involved in hydrogen peroxide-mediated disruption of tight junctions in Caco-2 cells monolayers. Our present study demonstrates that PP2A is involved in acetaldehyde-induced disruption of tight junctions.
The present study indicates that PP2A inhibition by fostriecin also attenuates acetaldehydeinduced redistribution of E-cadherin and β-catenin, suggesting that acetaldehyde-induced disruption of the adherens junction is also mediated by PP2A activity. The adherens junction is not a physical barrier to macromolecular transport across the epithelium. However, it is known to indirectly regulate the integrity of tight junctions, and therefore influence the barrier function. Previous studies indicated that redistribution of E-cadherin and β-catenin plays a crucial role in acetaldehyde-induced barrier dysfunction in Caco-2 cell monolayers (38) .
A significant body of evidence indicates that tight junctions are regulated by protein phosphorylation.
Occludin is phosphorylated on serine and threonine residues, and this phosphorylation is regulated by protein kinases such as c-Src, c-Yes, PKCη, PKCζ and CK2 (14, 41) and protein phosphatases such as PTP1B, PP1 and PP2A (36) (37) (38) . Our data show that acetaldehyde induces a rapid dephosphorylation of occludin and threonine residues. The occludin dephosphorylation was effectively blocked by fostriecin, indicating that PP2A played a role in this effect of acetaldehyde. Co-immunoprecipitation studies demonstrated that acetaldehyde increased the association of PP2A with occludin, indicating an enhanced interaction of PP2A with the tight junction protein complex. Previous studies showed that PP2A directly binds to the C-terminal domain of occludin (33, 37) . Therefore, it is likely that acetaldehyde enhances the direct interaction between occludin and PP2A.
Further studies were conducted to seek insight into the mechanism of acetaldehyde-induced PP2A translocation and occludin phosphorylation on threonine residues. Sub-cellular translocation of PP2A is known to be regulated by posttranslational modification at the C-terminal sequence TPDYFL (6, 11, 26) . Previous studies demonstrated that a synthetic peptide with this sequence attenuated PP2A translocation in cardiac myocytes (7) . Our present study demonstrates that TPDYFL prevented acetaldehyde-induced tight junction disruption and barrier dysfunction, indicating that PP2A translocation is an essential step in the mechanism of acetaldehyde-induced tight junction disruption.
Prevention of acetaldehyde-induced tight junction disruption by TPDYFL suggested that the acetaldehyde-induced PP2A translocation may be mediated by tyrosine phosphorylation or carboxymethylation. Phosphorylation of Y307 in the TPDYFL sequence of PP2A influences the interaction between the B-subunit and the AC-dimer of PP2A (26) . Similarly, methylation of L309 is required for the interaction of PP2A C-subunit with the B-subunit (6). Our study shows that methylated PP2A is present in the untreated Caco-2 cells, but acetaldehyde failed to alter the level of methyl-PP2A, indicating that methylation is not involved in the mechanism of acetaldehyde-induced PP2A translocation, occludin dephosphorylation or tight junction disruption.
Another mechanism by which PP2A translocation may be regulated is phosphorylation of Y307 (26) . Our previous study demonstrated that tyrosine kinase is involved in acetaldehyde-induced tight junction disruption (3). In the present study, the prevention of acetaldehyde-induced increase in association of PP2A with occludin and occludin dephosphorylation on threonine indicate that tyrosine kinase activity does play a role in acetaldehyde-induced PP2A translocation. According to the previous study, phosphorylation of PP2A on Y307 negatively regulates its interaction with the Bsubunit (26) . Y307E mutation of PP2A C-subunit leads to loss of its interaction with the B-subunit and alters its substrate specificity. Therefore, we speculate that tyrosine kinase activity and tyrosine phosphorylation of PP2A may increase its affinity for occludin, causing dephosphorylation of occludin on threonine residues. Our study also shows that acetaldehyde induces dephosphorylation of claudin-5 on threonine residues. However, genistein failed to prevent this dephosphorylation, indicating that the mechanism of claudin-5 dephosphorylation is distinct from that of occludin dephosphorylation. This study demonstrates that PP2A translocation plays a crucial role in acetaldehyde-induced disruption of tight junctions and increase in paracellular permeability in the intestinal epithelium.
Acetaldehyde-induced PP2A translocation to tight junctions is likely mediated by protein tyrosine phosphorylation. PP2A-mediated occludin dephosphorylation on threonine residues is an integral part of the mechanism involved in acetaldehyde-induced tight junction disruption. Values are mean ± sem (n = 4). Asterisk indicates the value that is significantly different from the value for control cell monolayer. prior to exposure to 400 μM acetaldehyde for 1 hour. Cryosections of these tissues were fixed and double-stained for occludin (green) and ZO-1 (red). Images collected by using a laser scanning confocal microscope. This experiment was repeated twice with similar results.
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